Quick Takeaways
- Roger Jeffs has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $110,536,852.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Roger Jeffs
- Summary
- The estimated net worth of Roger Jeffs is at least $110,536,852 dollars as of 21 Apr 2026. Roger Jeffs is the Chief Executive Officer, Director of Liquidia Corp and owns shares of Liquidia Corp (LQDA) stock worth about $103.42M. Roger Jeffs is the Director of Axsome Therapeutics, Inc. and owns shares of Axsome Therapeutics, Inc. (AXSM) stock worth about $7.12M.
- Signature
- /s/ Roger Jeffs
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Roger Jeffs and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Liquidia Corp ($103,419,088).
- Past-year value change for that position: -$10,092,801.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Roger Jeffs
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LQDA | Liquidia Corp | Chief Executive Officer, Director | $103,419,088 | -$10,092,801 | -8.9% | 17 Apr 2026 |
| AXSM | Axsome Therapeutics, Inc. | Director | $7,117,764 | -$13,373,843 | -65% | 02 Sep 2025 |
| ALBO | ALBIREO PHARMA, INC. | Director | 24 Jun 2021 |
Insider Transactions Reported by Roger Jeffs:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.